EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Incremental diagnostic yield of consecutive sputum nucleic acid amplification tests for pulmonary tuberculosis

Takumi Kanokogi iD, Naohisa Urabe iD, Nozomi Tokita, Hinako Murakami, Masakazu Sasaki, Susumu Sakamoto, Kazuma Kishi

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.02442-25 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Takumi Kanokogi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, Japan. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Nucleic Acid Amplification Techniques, Sputum, Tuberculosis, Pulmonary. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incremental diagnostic yield of consecutive sputum nucleic acid amplification tests (NAATs) for pulmonary tuberculosis (PTB) is not well established. We aimed to assess the diagnostic performance of one to three consecutive sputum NAATs in a non-high-tuberculosis-burden setting. We retrospectively analyzed data from 4,051 patients with suspected PTB in Japan between 2010 and 2023. Patients with a positive culture or a positive NAAT consistent with clinical findings were classified into the PTB group ( n = 290); all others were classified into the non-PTB group ( n = 3,761). We evaluated the cumulative sensitivity and specificity of smear microscopy, NAAT, and culture for one, two, and three sputum specimens and compared the time to microbiological diagnosis for culture alone versus culture combined with one, two, or three sputum NAATs. In the PTB group, a second NAAT substantially increased cumulative sensitivity from 53.1% to 63.1% (+10.0%) and shortened the mean time to diagnosis from 10.9 to 8.3 days (−2.6 days). A third NAAT provided minimal additional benefit, increasing sensitivity to 67.2% (+4.1%) and reducing the time to diagnosis to 8.1 days (−0.2 days). In smear-positive PTB, the NAAT sensitivity increased from an already high 84.9% with a single test to 97.8% with a second test. Similarly, in smear-negative patients, sensitivity increased from 23.8% to 31.1%. In a non-high-tuberculosis-burden setting, performing a second sputum NAAT significantly improves diagnostic sensitivity and shortens the time to diagnosis. IMPORTANCE The standard diagnostic protocol for pulmonary tuberculosis still relies on collecting three consecutive sputum specimens to maximize the diagnostic yield of smear and culture. While nucleic acid amplification tests (NAATs) have become increasingly important diagnostic tools, the incremental value of this approach for sputum NAAT-based diagnosis has remained uncertain. In a large cohort from a non-high-tuberculosis-burden setting, we show that adding a second sputum NAAT meaningfully improves cumulative sensitivity and shortens the mean time to diagnosis, whereas a third sputum NAAT provides only modest additional benefit. Notably, a two-sputum NAAT strategy optimizes yield irrespective of smear status, achieving saturation in smear-positive cases and securing a modest but steady stepwise gain in sensitivity for smear-negative patients. Therefore, our findings provide crucial evidence to support a two-sputum NAAT strategy to optimize the diagnostic workflow for PTB in non-high-tuberculosis-burden settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisNucleic Acid Amplification TechniquesSputumTuberculosis, PulmonaryAdultAgedFemaleHumansMaleMiddle AgedBacilloscopyJapanMolecular Diagnostic TechniquesRetrospective StudiesSensitivity and Specificity

Stichwörter der Autor:innen

Mycobacterium tuberculosisNAATTB-PCRthree consecutive sputum specimens

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, Japan.
  • Department of Respiratory Medicine, Toho University Graduate School of Medicine, Tokyo, Japan.
  • Department of Clinical Laboratory, Toho University Omori Medical Center, Tokyo, Japan.

ORCID-Profile: Takumi Kanokogi, Naohisa Urabe

Zitieren

APA

Kanokogi, T., Urabe, N., Tokita, N., Murakami, H., Sasaki, M., Sakamoto, S., & Kishi, K. (2026). Incremental diagnostic yield of consecutive sputum nucleic acid amplification tests for pulmonary tuberculosis. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02442-25

Vancouver

Kanokogi T, Urabe N, Tokita N, Murakami H, Sasaki M, Sakamoto S, et al. Incremental diagnostic yield of consecutive sputum nucleic acid amplification tests for pulmonary tuberculosis. Microbiology Spectrum. 2026. doi:10.1128/spectrum.02442-25

BibTeX
@article{Kanokogi2026,
  author = {Kanokogi, Takumi and Urabe, Naohisa and Tokita, Nozomi and Murakami, Hinako and Sasaki, Masakazu and Sakamoto, Susumu and Kishi, Kazuma},
  title = {Incremental diagnostic yield of consecutive sputum nucleic acid amplification tests for pulmonary tuberculosis},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.02442-25}
}
Kostenlos starten →